Correlation Between Pfizer and PetroShale
Can any of the company-specific risk be diversified away by investing in both Pfizer and PetroShale at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and PetroShale into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and PetroShale, you can compare the effects of market volatilities on Pfizer and PetroShale and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of PetroShale. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and PetroShale.
Diversification Opportunities for Pfizer and PetroShale
0.72 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Pfizer and PetroShale is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and PetroShale in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PetroShale and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with PetroShale. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PetroShale has no effect on the direction of Pfizer i.e., Pfizer and PetroShale go up and down completely randomly.
Pair Corralation between Pfizer and PetroShale
Considering the 90-day investment horizon Pfizer Inc is expected to generate 0.57 times more return on investment than PetroShale. However, Pfizer Inc is 1.75 times less risky than PetroShale. It trades about -0.06 of its potential returns per unit of risk. PetroShale is currently generating about -0.2 per unit of risk. If you would invest 2,787 in Pfizer Inc on September 3, 2024 and sell it today you would lose (166.00) from holding Pfizer Inc or give up 5.96% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Pfizer Inc vs. PetroShale
Performance |
Timeline |
Pfizer Inc |
PetroShale |
Pfizer and PetroShale Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pfizer and PetroShale
The main advantage of trading using opposite Pfizer and PetroShale positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, PetroShale can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PetroShale will offset losses from the drop in PetroShale's long position.Pfizer vs. Merck Company | Pfizer vs. Johnson Johnson | Pfizer vs. Highway Holdings Limited | Pfizer vs. QCR Holdings |
PetroShale vs. Dno ASA | PetroShale vs. Horizon Oil Limited | PetroShale vs. Enwell Energy plc | PetroShale vs. Tullow Oil plc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |